Stocks › TWST

Twist Bioscience Corp

TWST·Nasdaq·United States United States·USD
$103.32
-8.30 (-7.44%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
TWST
Twist Bioscience Corp · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
TWSTS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of TWST by members of U.S. Congress · 2 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Dwight EvansDwight EvansHouse · D · PA TWSTTwist Bioscience Corp · Stock Sale
$1,001 - $15,000
Apr 25, 2022 Mar 30, 2022 Filing ↗
Dwight EvansDwight EvansHouse · D · PA TWSTTwist Bioscience Corp · Stock Purchase
$1,001 - $15,000
Apr 23, 2020 Mar 2, 2020 Filing ↗

Whale Activity

Position changes in TWST reported for 2026-09-30 by 476 institutional filers
Increased: 127New: 132Held: 37Decreased: 120Closed: 39No prior filing: 21
  • Increased127
  • New132
  • Held37
  • Decreased120
  • Closed39
  • No prior filing21
FilerSharesValueChange
FMR LLC9.7M$1.87Bincreased
BlackRock, Inc.6.4M$1.23Bincreased
PRICE T ROWE ASSOCIATES INC /MD/6.1M$1.18Bincreased
ARK Investment Management LLC3.4M$656.6Mdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC3.1M$603.4Mincreased
STATE STREET CORP3.0M$583.0Mdecreased
VANGUARD CAPITAL MANAGEMENT LLC3.0M$575.3Mincreased
FARALLON CAPITAL MANAGEMENT, L.L.C.2.1M$412.8Mheld
Artisan Partners Limited Partnership2.0M$395.1Mdecreased
D. E. Shaw & Co., Inc.1.8M$352.9Mincreased
Invesco Ltd.1.8M$352.1Mdecreased
GEODE CAPITAL MANAGEMENT, LLC1.7M$336.2Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by TWST insiders, by quarter · Form 4
-1.0M-500.0K0500.0K1.0M2025 Q1: -41.7K2025 Q12025 Q2: -54.0K2025 Q22025 Q3: -30.3K2025 Q32025 Q4: -184.9K2025 Q42026 Q1: -212.6K2026 Q12026 Q2: -222.3K2026 Q22026 Q3: -702.3K2026 Q32026 Q4: -148.8K2026 Q4

Recent Insider Transactions

1,847 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Cho DennisSee Remarks Sale −5,427 $103.69 $563K Nov 16, 2026 Form 4 ↗
Finn Patrick JohnPresident and COO Sale −12.8K $103.69 $1.3M Nov 16, 2026 Form 4 ↗
Green PaulaSVP of Human Resources Sale −4,281 $103.69 $444K Nov 16, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −19.0K $103.69 $2.0M Nov 16, 2026 Form 4 ↗
WERNER ROBERT F.Chief Accounting Officer Sale −1,637 $103.69 $170K Nov 16, 2026 Form 4 ↗
Laponis AdamChief Financial Officer Sale −6,359 $103.69 $659K Nov 16, 2026 Form 4 ↗
Green PaulaSVP of Human Resources Sale +20.4K $0.00 $0 Nov 12, 2026 Form 4 ↗
Cho DennisSee Remarks Sale −949 $135.40 $128K Nov 3, 2026 Form 4 ↗
Finn Patrick JohnPresident and COO Sale −2,565 $135.40 $347K Nov 3, 2026 Form 4 ↗
Green PaulaSVP of Human Resources Sale −1,007 $135.40 $136K Nov 3, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −4,573 $135.40 $619K Nov 3, 2026 Form 4 ↗
WERNER ROBERT F.Chief Accounting Officer Sale −148 $135.40 $20K Nov 3, 2026 Form 4 ↗
Finn Patrick JohnPresident and COO Sale −2,245 $134.59 $302K Oct 23, 2026 Form 4 ↗
Laponis AdamChief Financial Officer Sale −2,462 $156.30 $385K Oct 9, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −481 $201.26 $97K Oct 5, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −45 $207.46 $9K Oct 5, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −432 $203.61 $88K Oct 5, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −297 $205.78 $61K Oct 5, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −290 $204.80 $59K Oct 5, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −1,840 $200.44 $369K Oct 5, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding TWST · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.9M$192.8M0.01%Jun 30, 2026
ARK Innovation ETF
ARK ETF Trust
2.0M$184.1M3.31%Jul 31, 2026
iShares Russell 2000 ETF
iShares Trust
1.6M$164.0M0.20%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF
SPDR SERIES TRUST
1.5M$151.1M1.41%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
1.4M$139.6M0.07%Jun 30, 2026
ARK Genomic Revolution ETF
ARK ETF Trust
1.3M$120.4M7.73%Jul 31, 2026
Invesco Discovery Fund
AIM Counselor Series Trust (Invesco Counselor Series Trust)
835.6K$116.1M1.57%Aug 31, 2026
T. Rowe Price New Horizons Fund, Inc.959.3K$98.7M0.67%Jun 30, 2026
Artisan Mid Cap Fund
Artisan Partners Funds Inc.
893.2K$91.9M2.88%Jun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund
Bridge Builder Trust
866.9K$89.2M0.80%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list TWST's shares (CUSIP 90184D100), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • T. Rowe Price Associates, Inc.SCHEDULE 13G/A · passive (13G) · 6.1M shares9.2%
    Nov 16, 2026 · ↗
  • Artisan Partners Limited PartnershipSCHEDULE 13G/A · passive (13G) · 2.0M shares3.4%
    Nov 12, 2026 · ↗
  • Artisan Investments GP LLCSCHEDULE 13G/A · passive (13G) · 2.0M shares3.4%
    Nov 12, 2026 · ↗
  • Artisan Partners Holdings LPSCHEDULE 13G/A · passive (13G) · 2.0M shares3.4%
    Nov 12, 2026 · ↗
  • Artisan Partners Asset Management Inc.SCHEDULE 13G/A · passive (13G) · 2.0M shares3.4%
    Nov 12, 2026 · ↗
  • STATE STREET CORPORATIONSCHEDULE 13G · passive (13G) · 3.0M shares4.6%
    Nov 10, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 9.5M shares14.4%
    Nov 5, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 9.5M shares14.4%
    Nov 5, 2026 · ↗
  • Catherine D. WoodSCHEDULE 13G/A · passive (13G) · 3.4M shares5.1%
    Sep 8, 2026 · ↗
  • ARK Investment Management LLCSCHEDULE 13G/A · passive (13G) · 3.4M shares5.1%
    Sep 8, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming twist bioscience as client
$0$125K$250K$375K$500K2023 Q1: $29K2023 Q2: $44K2023 Q3: $44K2023 Q4: $44K20232024 Q1: $46K2024 Q2: $46K2024 Q3: $47K2024 Q4: $47K20242025 Q1: $75K2025 Q2: $75K2025 Q3: $75K2025 Q4: $75K20252026 Q1: $83K2026 Q2: $83K2026 Q3: $83K2026
  • IPOLICY SOLUTIONSTWIST BIOSCIENCE CORPORATION · 2026 Q3 · SCI, TRD$83K
    Filing ↗
  • IPOLICY SOLUTIONSTWIST BIOSCIENCE CORPORATION · 2026 Q2 · SCI, TRD$83K
    Filing ↗
  • IPOLICY SOLUTIONSTWIST BIOSCIENCE CORPORATION · 2026 Q1 · SCI, TRD$83K
    Filing ↗
  • IPOLICY SOLUTIONSTWIST BIOSCIENCE CORPORATION · 2025 Q4 · SCI, DEF, TRD$75K
    Filing ↗
  • IPOLICY SOLUTIONSTWIST BIOSCIENCE CORPORATION · 2025 Q3 · INT, CPT, SCI$75K
    Filing ↗

Government Contracts

Federal awards to twist bioscience · USAspending
$228KAwarded · 4 contracts on record
  • Department of Veterans AffairsSHAHRARA HUMANIZED MONOCLONAL ANTIBODY FOR SYNDECAN TWIST BIOSCIENCE$105K
    Sep 18, 2024 · ↗
  • Department of Health and Human ServicesTHE PURPOSE OF THIS PURCHASE ORDER IS TO PROVIDE THE NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES / DIVISION OF TRANSLATIONAL TOXICOL$27K
    Jul 30, 2026 · ↗
  • Department of Health and Human ServicesTWIST BIOSCIENCE$0
    Dec 18, 2020 · ↗
  • Department of JusticeTWIST BIOSCIENCE EQUIPMENT$97K
    Jun 29, 2026 · ↗

U.S. Patents

Recent USPTO applications naming Twist Bioscience Corp

No USPTO patent applications found for Twist Bioscience Corp.

Annual Financials

From TWST's 10-K filings · XBRL
Fiscal yearFY2026FY2025FY2024FY2023FY2022
Operating income-$139.5M-$136.3M-$220.8M-$217.2M-$234.8M
Net income-$130.2M-$77.7M-$208.7M-$204.6M-$217.9M
Diluted EPS-$2.08-$1.30-$3.60-$3.60-$4.04
Operating cash flow-$41.4M-$47.6M-$64.1M-$142.5M-$124.4M
Cash and equivalents$534.0M$183.0M$226.3M$286.5M$378.7M
Total assets$1.12B$641.9M$614.3M$776.4M$961.4M
Total liabilities$233.8M$168.9M$141.6M$153.0M$172.0M
Shareholders' equity$888.0M$473.0M$472.7M$623.4M$789.4M

As Twist Bioscience Corp tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Nov 16, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in TWST's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 12, 2026
    EDGAR ↗
  • 8-K · Items 7.01Reg FD disclosureAug 19, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsAug 19, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 7.01, 9.01Material agreement · Reg FD disclosureAug 5, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 3, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 4, 2026
    EDGAR ↗

About Twist Bioscience Corp

From SEC EDGAR company records

Twist Bioscience Corporation provides customizable solutions across the biological continuum, helping customers read, write and innovate in biology. Across diagnostics, therapeutics, industrial, agriculture and research markets, our customers use our products and services to develop ways to improve human health and the sustainability of the planet. Our goal is to enable them to do this work with confidence, without having to compromise on quality, speed, scale or cost. We believe that the faster our customers succeed, the better for all of us. At the core of our business is a proprietary platform that allows us to manufacture synthetic DNA by “writing” DNA on a silicon chip. We have miniatur…

Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersSOUTH SAN FRANCISCO, CA
IncorporatedDE